7163 studies found for:    INS
Show Display Options
Rank Status Study
1 Recruiting Regulation of Endogenous Glucose Production by Brain Insulin Action
Condition: Insulin Resistance, Diabetes
Intervention: Drug: Intranasal insulin
2 Completed Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Long-acting bedtime insulin detemir (Levemir);   Drug: Insulin detemir and pre-meal insulin aspart.
3 Completed Topic Insulin Accelerates Wound Healing in Diabetes
Conditions: Diabetes Mellitus;   Wounds
Intervention: Drug: topic cream insulin
4 Completed Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Insulin aspart
5 Not yet recruiting Self-management of Type 1 Diabetes Under Functional Insulin Therapy
Conditions: Type 1 Diabetes;   Basal-bolus Multiple-dily Insulin Injections;   Insulin Pump (CSII)
Interventions: Other: Training course to functional insulin therapy;   Other: Usual diabetes management.
6 Completed
Has Results
Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
Condition: Diabetes Mellitus
Interventions: Drug: MDI (split-mix NPH insulin + regular insulin or Lantus + Novolog® [or Humalog®]);   Device: CSII (Animas Corporation insulin pump, model IR 1200)
7 Enrolling by invitation Comparison Study of Insulin Glargine and NPH Insulin
Condition: Diabetes
Interventions: Drug: Switching to NPH insulin;   Drug: Continuation of insulin glargine
8 Recruiting Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Condition: Type 2 Diabetes
Interventions: Drug: Basal insulin and exenatide;   Drug: Basal insulin only;   Drug: Basal insulin and bolus insulin
9 Completed
Has Results
Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Lispro Low Mixture (LM);   Drug: Insulin Glargine;   Drug: Prandial Insulin Lispro
10 Not yet recruiting PK/PD STUDY OF U-500 REGULAR INSULIN
Conditions: Type 2 Diabetes;   Insulin Resistance;   High Insulin Requirements
Intervention: Drug: U-500 insulin
11 Enrolling by invitation Insulin Infusion Diabetes Ulcer
Conditions: Diabetes Mellitus;   Insulin Resistance;   Hyperglycemia;   Surgery;   Ulcers;   Infection
Intervention: Procedure: Insulin infusion
12 Completed
Has Results
Comparison of Insulins Aspart and Lispro in Insulin Pumps
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin Aspart;   Drug: Insulin Lispro
13 Completed Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Regular insulin (Humulin);   Drug: Insulin lispro (Humalog)
14 Completed Insulin Therapy in the Hospital Comparing Two Protocols
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine insulin;   Drug: NPH insulin and regular insulin;   Drug: lispro insulin
15 Completed FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)];   Drug: Insulin glargine, metformin, prandial insulin
16 Unknown  Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Condition: Insulin-requiring Type 2 Diabetes Mellitus
Interventions: Drug: nph insulin;   Drug: human insulin;   Drug: Insulin Glargine;   Drug: Insulin glulisine
17 Completed A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients
Condition: Diabetes Mellitus
Interventions: Drug: Insulin (recombinant human insulin);   Drug: NovoLog
18 Unknown  The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
19 Recruiting Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition
Condition: Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
Interventions: Drug: Glargine Insulin;   Drug: Regular insulin
20 Completed
Has Results
Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin aspart;   Drug: Recombinant human hyaluronidase PH20 (rHuPH20)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years